I-Metoclopramide (Reglan), i-Domperidone (i-Motilium) ne-Breastfeeding
Impela ayikho imithi etholakalayo eyenziwe ngokukhethekile ekwandiseni ukondla ubisi lwebele , kodwa kukhona izidakamizwa zemithi eyenzelwe ezinye izimo ezisetshenziselwa leyo njongo.
Indlela Abasebenza ngayo
Le mithi ibangela ukwanda kwezinga leprolactin , i-hormone ebhekene nokukhiqizwa ubisi, ngakho banomthelela ohlangothini wokwenza ubisi lwebele.
Ngaphansi kokuqondiswa ngqo nokuqapha udokotela, le mithi inqunyelwe ukusiza ukudala, ukuvuselela kabusha noma ukwandisa ukunikezwa kobisi lwebele kumama ohlengikazi.
Izizathu Zibhalwe
- Ungathanda ukuncelisa ingane eyamukelwe
- Usulile ingane yakho futhi ungathanda ukuqala ukunakekela futhi
- Utshela ingane esibhedlela futhi ukunikezwa kwakho ubisi kuphansi
Uma uzame ukwandisa ukondla ubisi ngokwemvelo nangokwelashwa kwemithi, kodwa ube nomphumela omncane noma awukho, funda udokotela wakho ukuze ubone ukuthi imithi yokwelapha ikulungele yini.
Imithwalo Yemizila Yomuthi
Yonke imithi ibe nemiphumela emibi futhi ingaba yingozi, ngakho ungalokothi uqale noma yimiphi imithi ngaphandle kokuqala ukuxoxa ngayo nomhlinzeki wakho wezempilo, ikakhulukazi uma ukhulelwe noma uncelisa.
Uma wena nodokotela wakho benquma ukuthi uzozuza emtholampilo, qiniseka ukuthi uyithatha njengoba nje ulayishiwe, futhi ulandele njalo nodokotela wakho njalo.
Kubalulekile futhi ukuqonda ukuthi imithi ngokwayo ayanele ukwakhiwa noma ukwandisa ukondla ubisi lwakho. Ukuhlengikaza njalo kanye / noma ukuphoqa ukugqugquzela amabele nokususa ubisi kuyadingeka.
Imithi Ekhethiwe Ngokuvamile
Imithi emibili evame ukusetshenziswa njengama- galactagogues yi-metoclopramide (Reglan) ne- domperidone (i-Motilium).
I-Metoclopramide (Reglan)
- I-Metoclopramide imithi esetshenziselwa ukwelapha izinkinga zesisu ezifana ne-reflux, i-nausea nokuhlanza. Iyisisetshenziswa esivame ukusetshenziswa kakhulu sokungeniswa kwe-lactation nokukhulisa ubisi oluncane lwebele e-United States.
- Imiphumela ingavame ukubonakala ezinsukwini ezimbalwa, futhi ngokuvamile iyohlala isikhathi eside uma imithi iqhubeka. Ukuhlinzekwa ngokuvamile kuvambela futhi uma imithi ingasetshenzisiwe.
- I-Metoclopramide ihambela umntwana ngokusebenzisa ubisi lwebele, kodwa ayizange ibonwe ukuthi ibangele izinkinga ezinganeni ezisencane.
- Imiphumela emibi ejwayelekile ye-metoclopramide yi-sleepiness, i-headache, noma i-restlessness. Imiphumela emibi engavamile, kodwa embi kakhulu kubikwe futhi ngokusetshenziswa kwalo muthi.
- I-US Food and Drug Administration (FDA) ixwayisa ukuthi ukucindezeleka kanye ne-tardive dyskinesia, isimo esibangela ama-tics, ukuthuthumela noma ukunyakaza okungaqondakali kobuso nomzimba, kungabangela ukuthatha i-metoclopramide ngokulinganisa okuphezulu isikhathi eside. Kwezinye izimo, ukunyakaza okuzimele akuxazululwe ngisho nangemva kokuba imithi imisiwe.
- I-Metoclopramide akufanele ithathwe isikhathi esingaphezu kwamasonto angu-12, futhi akufanele isetshenziswe yinoma ubani ohluphekile, isifo sokuthumba, isifo se-asthma noma umfutho wegazi ophezulu.
I-Domperidone (i-Motilium)
- I-Domperidone , njenge-metoclopramide, isetshenziselwa ukuphatha izinkinga zesisu. Ayitholakali e-United States, kepha isetshenziswa kakhulu eCanada nakwamanye amazwe ukukhuthaza ukukhiqizwa ubisi lwebele.
- Ngaphandle kwe-US, i-domperidone ikholelwa ukuthi ivikelekile kune-metoclopramide, enezimbangela ezimbalwa zabamama abahlengikazi. Kucatshangwa ukuthi kuphephile ukuthatha isikhathi eside. Imiphumela emibi efana nokukhanda ikhanda, izimpande zesisu nomlomo omile kungenzeka, kepha kuvame ukungajwayelekile.
- E-United States, i-FDA ayizange ivumele i-domperidone nganoma yisiphi isimo. Ixwayisa ngokusetshenziswa kwalesi sidakamizwa kunoma ubani, ikakhulukazi abesifazane abancancisayo.
- Imibiko yezinkinga ezinkulu zenhliziyo nokufa okungazelelwe kuye kwahlotshaniswa nokusetshenziswa okuyi-intravenous (IV) yalo muthi, ngakho-ke i-FDA ibona ingaphephile. Ngakho-ke, e-US, akuvumelekile ukungenisa, ukuthengisa noma ukwakha i-domperidone ngaphandle kweziguli ezithile ezinezinkinga ezinkulu zesisu, futhi emva nje kokuba udokotela ethumele isicelo esikhethekile ku-FDA.
Eminye Imithi
Ama-trillizers ezifana ne-chlorpromazine (i-Thorazine) ne-haloperidol (i-Haldol), kanye nemithi ye-blood pressure i-methyldopa (i-Aldomet) ingenye yeminye imiyalelo engakhuphula izinga le-prolactin emzimbeni futhi ingase yande ukondla ubisi lwebele.
Noma kunjalo, imiphumela emibi evela kulezi zidakamizwa ingaba yingozi kakhulu. Izingozi lezi mithi zibangelwa omama abahlengikazi abangaphezu kwezinzuzo, ngakho-ke azisebenzisi ukuthuthukisa ubisi.
Imithombo:
I-American Academy of Pediatrics. Umhlahlandlela Womama Omusha Wokuncelisa I-Breastfeeding. Izincwadi ze-Bantam. I-New York. 2011.
Lawrence, uRuth A., MD, Lawrence, uRobert M., MD. Ukuncelisa ukubeletha Umhlahlandlela Wezokwelapha Umsebenzi we-Sixth Edition. Mosby. Philadelphia. 2005.
UNewman, Jack, MD, Pitman, Theresa. Incwadi Yokugcina Yokuncelisa Izimpendulo. I-Press Rivers Three. I-New York. 2006.
Ukuphathwa kwe-US nokuDrug. I-Domperidone. UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu. Juni 19, 2009. Kufinyelelwe ngoJanuwari 7, 2013: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154914.htm
Ukuphathwa kwe-US nokuDrug. I-FDA idinga ukuxwayiswa nge-Boxed and Risk Reducing Strategy for Metoclopramide-With Drugs. UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu. Ngo-February 26, 2009. Kufinyelelwe ngoJanuwari 7, 2013: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm149533.htm
Ukuphathwa kwe-US nokuDrug. I-FDA Paper Paper: I-FDA Ixwayisa Abesifazane Ngokusebenzisa Imithi Engavumelekile, i-Domperidone, Ukwandisa Ukukhiqizwa Kwamanzi. UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu. NgoJulayi 28, 2009. Kufinyelelwe ngoJanuwari 7, 2013: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm
Ukuphathwa kwe-US nokuDrug. Indlela Yokuthola I-Domperidone. UMnyango WezeMpilo waseMelika kanye Nezinsizakalo Zabantu. Ngo-Okthoba 1, 2008. Kufinyelelwe ngoJanuwari 7, 2013: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm073070.htm